Cropley Vanessa L, Fujita Masahiro, Bara-Jimenez William, Brown Amira K, Zhang Xiang-Yang, Sangare Janet, Herscovitch Peter, Pike Victor W, Hallett Mark, Nathan Pradeep J, Innis Robert B
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-0135, USA.
Psychiatry Res. 2008 Jul 15;163(2):171-82. doi: 10.1016/j.pscychresns.2007.11.003. Epub 2008 May 27.
Frontostriatal cognitive dysfunction is common in Parkinson disease (PD), but the explanation for its heterogeneous expressions remains unclear. This study examined the dopamine system within the frontostriatal circuitry with positron emission tomography (PET) to investigate pre- and post-synaptic dopamine function in relation to the executive processes in PD. Fifteen non-demented PD patients and 14 healthy controls underwent [(18)F]FDOPA (for dopamine synthesis) and [(11)C]NNC 112 (for D(1) receptors) PET scans and cognitive testing. Parametric images of [(18)F]FDOPA uptake (K(i)) and [(11)C]NNC 112 binding potential (BP(ND)) were calculated using reference tissue models. Group differences in K(i) and BP(ND) were assessed with both volume of interest and statistical parametric mapping, and were correlated with cognitive tests. Measurement of [(18)F]FDOPA uptake in cerebral cortex was questionable because of higher K(i) values in white than adjacent gray matter. These paradoxical results were likely to be caused by violations of the reference tissue model assumption rendering interpretation of cortical [(18)F]FDOPA uptake in PD difficult. We found no regional differences in D(1) receptor density between controls and PD, and no overall differences in frontostriatal performance. Although D(1) receptor density did not relate to frontostriatal cognition, K(i) decreases in the putamen predicted performance on the Wisconsin Card Sorting Test in PD only. These results suggest that striatal dopamine denervation may contribute to some frontostriatal cognitive impairment in moderate stage PD.
额前叶纹状体认知功能障碍在帕金森病(PD)中很常见,但其异质性表现的原因尚不清楚。本研究采用正电子发射断层扫描(PET)检查额前叶纹状体回路中的多巴胺系统,以探讨与PD执行过程相关的突触前和突触后多巴胺功能。15名非痴呆PD患者和14名健康对照者接受了[(18)F]FDOPA(用于多巴胺合成)和[(11)C]NNC 112(用于D(1)受体)PET扫描及认知测试。使用参考组织模型计算[(18)F]FDOPA摄取(K(i))和[(11)C]NNC 112结合潜力(BP(ND))的参数图像。用感兴趣区和统计参数映射评估K(i)和BP(ND)的组间差异,并与认知测试相关联。由于白质中的K(i)值高于相邻灰质,因此大脑皮层中[(18)F]FDOPA摄取的测量存在疑问。这些矛盾的结果可能是由于违反了参考组织模型假设,使得对PD中皮层[(18)F]FDOPA摄取的解释变得困难。我们发现对照组和PD组之间D(1)受体密度没有区域差异,额前叶纹状体表现也没有总体差异。虽然D(1)受体密度与额前叶纹状体认知无关,但仅在PD组中,壳核K(i)降低预示着威斯康星卡片分类测试的表现。这些结果表明,纹状体多巴胺去神经支配可能导致中度PD患者出现一些额前叶纹状体认知障碍。